SYNTHESIS AND TRANSFORMATIONS OF 9-SUBSTITUTED IMIDAZO[1,2-a]...
1163
Chalcones 4 and 5 (general procedure). A solution
of 2 mmol of aldehyde 2 or 3 and 2 mmol of the
corresponding ketone in 5 mL of ethanol containing
a catalytic amount of 40% aqueous sodium hydroxide
was refluxed for 5–7 min. After cooling, the precipitate
was filtered off and washed with ethanol and diethyl
ether.
(3H, CH3), 7.22 t (1H, 6-H or 7-H, J = 7.8 Hz), 7.29 d
(1H, 8-H, J = 8.0 Hz), 7.36 t (1H, 7-H or 6-H, J =
7.9 Hz), 7.54 d (1H, 5-H, J = 8.0 Hz), 7.66 s (1H, 3-H),
7.76 d and 7.85 d (1H each, CH=CH, J = 14.9 Hz),
8.22 d and 8.32 d (2H each, C6H4NO2, J = 8.5 Hz); in
DMSO-d6: 3.74 s (3H, CH3), 7.22 t (1H, 6-H or 7-H,
J = 7.8 Hz), 7.36 t (1H, 7-H or 6-H, J = 7.8 Hz), 7.54 d
(1H, 8-H, J = 8.1 Hz), 7.65 d and 7.78 d (1H each,
CH=CH, J = 14.9 Hz), 7.81 d (1H, 5-H, J = 7.9 Hz),
8.23 d (2H, C6H4NO2, J = 8.7 Hz), 8.29 s (1H, 3-H),
8.36 d (2H, C6H4NO2, J = 8.7 Hz). Found, %: C 66.12;
H 4.27; N 16.40. C19H14N4O3. Calculated, %: C 65.89;
H 4.07; N 16.18.
Ethyl 9-methyl-2-[(E)-3-(4-nitrophenyl)-3-oxo-
prop-1-en-1-yl]-9H-imidazo[1,2-a]benzimidazole-3-
carboxylate (4a). Yield 0.69 g (83%), orange crystals,
1
mp 226–227°C (from DMF). H NMR spectrum, δ,
ppm: 1.48 t (3H, CH2CH3, J = 7.1 Hz), 3.84 s (3H,
CH3), 4.49 q (2H, OCH2, J = 7.1 Hz), 7.26 t (1H, 6-H
or 7-H, J = 8.1 Hz), 7.30 d (1H, 8-H, J = 7.9 Hz), 7.39 t
(1H, 7-H or 6-H, J = 7.9 Hz), 7.93 d (1H, CH=, J =
15.2 Hz), 8.19 d and 8.31 d (2H each, C6H4NO2, J =
8.9 Hz), 8.51 d (1H, CH=, J = 15.2 Hz), 8.54 d (1H,
5-H, J = 7.9 Hz). Found, %: C 63.37; H 4.12; N 13.52.
C22H18N4O5. Calculated, %: C 63.15; H 4.34; N 13.39.
(E)-1-(1,1′-Biphenyl-4-yl)-3-(9-methyl-9H-imid-
azo[1,2-a]benzimidazol-2-yl)prop-2-en-1-one (5b).
Yield 0.51 g (69%), bright yellow crystals, mp 223–
1
224°C (from BuOH). H NMR spectrum, δ, ppm:
3.84 s (3H, CH3), 7.21–7.69 m (10H, 3-H, 5-H, 6-H,
7-H, 8-H, C6H5), 7.73 d (2H, 2′-H, 6′-H, J = 8.4 Hz),
7.86 d and 7.90 d (1H each, CH=CH, J = 15.0 Hz),
8.22 d (2H, 3′-H, 5′-H, J = 8.4 Hz). Found, %: C 79.73;
H 4.80; N 11.42. C25H19N3O. Calculated, %: C 79.55;
H 5.07; N 11.13.
Ethyl 2-[(E)-3-(1,1′-biphenyl-4-yl)-3-oxoprop-1-
en-1-yl]-9-methyl-9H-imidazo[1,2-a]benzimidazole-
3-carboxylate (4b). Yield 0.65 g (72%), pale yellow
1
crystals, mp 239–241°C (from DMF). H NMR spec-
trum, δ, ppm: 1.50 t (3H, CH2CH3, J = 7.1 Hz), 3.84 s
(3H, CH3), 4.49 q (2H, OCH2, J = 7.1 Hz), 7.25–
7.47 m (6H, 6-H or 7-H, C6H5), 7.63–7.65 m (2H, 7-H
or 6-H, 8-H), 7.71 d (2H, 2′-H, 6′-H, J = 8.4 Hz), 8.04 d
(1H, CH=, J = 15.2 Hz), 8.16 d (2H, 3′-H, 5′-H, J =
8.4 Hz), 8.50 d (1H, CH=, J = 15.2 Hz), 8.55 d (1H,
5-H, J = 8.0 Hz). Found, %: C 74.98; H 5.03; N 9.57.
C28H23N3O3. Calculated, %: C 74.82; H 5.16; N 9.35.
Ethyl 2-{3-[(1,1′-biphenyl)-4-yl]-4,5-dihydro-1H-
pyrazol-5-yl}-9-methyl-9H-imidazo[1,2-a]benzimid-
azole-3-carboxylate (6). A solution of 0.45 g (1 mmol)
of 4b and 0.2 mL of hydrazine hydrate in 10 mL of
ethanol was refluxed for 45 min. After cooling, the
colorless solid was filtered off and washed with
acetone. Yield 0.32 g (69%), mp 187–189°C (from
1
i-PrOH). H NMR spectrum, δ, ppm: 1.52 t (3H,
CH2CH3, J = 7.0 Hz), 3.51–3.55 m and 3.68–3.74 m
(1H each, 4′-H), 3.81 s (3H, CH3), 4.52 q (2H, OCH2,
J = 7.0 Hz), 5.59–5.66 m (1H, 5′-H), 6.58 br.s (1H,
NH), 7.26–7.82 (12H, Harom), 8.50 d (1H, 5-H, J =
8.1 Hz). Found, %: C 72.68; H 5.27; N 14.88.
C28H25N5O2. Calculated, %: C 72.55; H 5.44; N 15.11.
Ethyl 9-methyl-2-[(E)-3-(naphthalen-1-yl)-3-oxo-
prop-1-en-1-yl]-9H-imidazo[1,2-a]benzimidazole-3-
carboxylate (4c). Yield 0.60 g (70%), yellow crystals,
1
mp 196–197°C (from BuOH). H NMR spectrum, δ,
ppm: 1.41 t (3H, CH2CH3, J = 7.1 Hz), 3.78 s (3H,
CH3), 4.28 q (2H, OCH2, J = 7.1 Hz), 7.28 t (1H, 6-H
or 7-H, J = 7.4 Hz], 7.42 t.d (1H, 7-H or 6-H, J = 7.4,
1.2 Hz), 7.57 d (1H, CH=, J = 15.5 Hz), 7.59–7.66 m
(4H, 3′-H, 5′-H, 6′-H, 7′-H), 7.84 d.d (1H, 8-H, J = 7.0,
1.2 Hz), 8.02–8.04 m (1H, 4′-H), 8.09 d (1H, CH=, J =
15.5 Hz), 8.13 d (8′-H, J = 8.3 Hz), 8.20–8.22 m (1H,
2′-H), 8.34 d (1H, 5-H, J = 8.1 Hz). Found, %: C 73.52;
H 5.23; N 10.18. C26H21N3O3. Calculated, %: C 73.74;
H 5.00; N 9.92
6-Methyl-2H-pyridazino[4′,5′:4,5]imidazo-
[1,2-a]benzimidazol-1(6H)-one (7). A solution of
0.42 g (1 mmol) of 1 in 5 mL of hydrazine hydrate was
refluxed for 0.5 h. After cooling, the precipitate was
filtered off and washed with water. Yield 0.21 g (88%),
1
colorless crystals, mp > 300°C (from DMF). H NMR
spectrum, δ, ppm: 3.85 s (3H, CH3), 7.37 t and 7.40 t
(1H, 8-H, 9-H, J = 7.1 Hz), 7.70 d (1H, 7-H, J =
8.1 Hz), 8.25 d (1H, 10-H, J = 8.0 Hz), 8.40 s
(1H, 4-H), 12.90 s (1H, NH). Found, %: C 60.12.15;
H 3.95; N 29.17. C12H9N5O. Calculated, %: C 60.25;
H 3.79; N 29.27.
(E)-3-(9-Methyl-9H-imidazo[1,2-a]benzimidazol-
2-yl)-1-(4-nitrophenyl)prop-2-en-1-one (5a). Yield
0.52 g (75%), orange crystals, mp 237–238°C (from
1
BuOH). H NMR spectrum, δ, ppm: in CDCl3: 3.81 s
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 56 No. 7 2020